• News
    • News by Region
      • College Station
      • Dallas/Fort Worth
      • El Paso
      • Galveston
      • Lubbock
      • San Antonio
      • Texas Cancer News: What You Need to Know
    • News by Topic
      • Alzheimer’s
      • Biofuels
      • Cancer
      • Cardiovascular
      • Diabetes
      • Genetics
      • Infectious Disease
      • Medical Device
      • Neurology
      • Vaccines
    • News by Institution
      • CPRIT
      • Baylor College of Medicine
      • Rice University
      • Texas A&M
      • Texas Heart Institute
      • UNT Health Science Center
      • UT Arlington
      • UT Austin
      • UT Dallas
      • UTHealth
      • UT MD Anderson Cancer Center
      • UT Medical Branch
      • UT Health Science Center San Antonio
      • University of Texas Southwestern Medical Center
    • Editorial Blog
  • Companies
    • Companies by City
      • Austin
        • Featured in Austin
      • College Station
      • Dallas
      • El Paso
      • Fort Worth
      • Galveston
      • Houston
        • Featured in Houston
      • Lubbock
      • San Antonio
      • Temple
      • Waco
    • Companies by Industry
      • Academic/Research
      • Biofuels
      • BioPharm Insurance
      • Biopharma
      • Biotech
      • Clinical Research
      • Contract Research
      • Cosmeceuticals
      • Diagnostics
      • Environmental
      • Featured
      • Genetics
      • Incubator/Accelerator
      • Legal
      • Manufacturing
      • Medical Devices
      • Pharmaceutical
      • Premium
      • Services
      • Supplements
      • Suppliers
      • Venture Capital
  • Service Providers
    • Services
      • Analytical Chemistry
      • Animal
      • Biochemistry
      • Bioprocess Contract
      • Biorepository
      • Cell Biology
      • Cell Culture
      • Chemistry
      • Clinical Research
      • Construction
      • Consulting
      • Contract Manufacturers
      • Contract Pharma
      • Contract Research
    • Suppliers
      • Biospecimens
      • Lab Equipment
      • Manufacturing
      • Meters
      • Microarrays
      • Microscopes
      • Miscellaneous
      • Molecular Biology
      • Packaging
      • Protein
      • Reagents
      • Research Tools
      • RNAi Technology
      • Safety & Hygiene
      • Sample Prep
      • Software Quality
      • Testing Systems
      • Vacuum Equipment
  • Channels
    • Regional Channels
      • Austin
      • College Station
      • Dallas / Fort Worth
      • El Paso
      • Galveston
      • Houston
      • Lubbock
      • San Antonio
    • Topic Channels
      • Alzheimer’s
      • Autism & Autism Spectrum Disorder: What You Need To Know
      • Autosomal Recessive Disease: What You Need To Know
      • Biofuels
      • Biomarkers: What You Need To Know
      • Biomaterials – Biospecimens
      • Brain Cancer: What You Need To Know
      • Cardiovascular
      • Chagas Disease: What You Need To Know
      • Cancer
      • Clostridium Difficile: What You Need To Know
      • Crohn’s Disease: What You Need To Know
      • Cystic Fibrosis: What You Need to Know
      • Dengue Fever: What You Need To Know
      • Depression
      • Ewing’s Sarcoma: What You Need To Know
      • Genetics
      • H7N9: What You Need To Know
      • Hepatitis B: What You Need To Know
      • Infectious Disease
      • Influenza: What You Need To Know
      • Leukemia: What You Need To Know
      • Liver Cancer: What You Need To Know
      • Lung Cancer: What You Need To Know
      • Medical Device
      • Myocardial Ischemia: What You Need To Know
      • Neglected Tropical Diseases: What You Need To Know
      • Neurology
      • Obesity: What You Need To Know
      • Peter Hotez: What You Need To Know
      • Prostate Cancer: What You Need To Know
      • Quantum Dots: What You Need To Know
      • Secondary Progressive MS: What You Need To Know
      • Spinal Muscular Atrophy: What You Need To Know
      • T-Cells: What You Need To Know
      • 3D Technology: What You Need To Know
      • Triple Negative Breast Cancer: What You Need To Know
      • West Nile Virus: What You Need To Know
  • About
  • Advertise

BioNews-TX

BioNews Texas

  • News
    • News by Region
      • College Station
      • Dallas/Fort Worth
      • El Paso
      • Galveston
      • Lubbock
      • San Antonio
      • Texas Cancer News: What You Need to Know
    • News by Topic
      • Alzheimer’s
      • Biofuels
      • Cancer
      • Cardiovascular
      • Diabetes
      • Genetics
      • Infectious Disease
      • Medical Device
      • Neurology
      • Vaccines
    • News by Institution
      • CPRIT
      • Baylor College of Medicine
      • Rice University
      • Texas A&M
      • Texas Heart Institute
      • UNT Health Science Center
      • UT Arlington
      • UT Austin
      • UT Dallas
      • UTHealth
      • UT MD Anderson Cancer Center
      • UT Medical Branch
      • UT Health Science Center San Antonio
      • University of Texas Southwestern Medical Center
    • Editorial Blog
  • Companies
    • Companies by City
      • Austin
        • Featured in Austin
      • College Station
      • Dallas
      • El Paso
      • Fort Worth
      • Galveston
      • Houston
        • Featured in Houston
      • Lubbock
      • San Antonio
      • Temple
      • Waco
    • Companies by Industry
      • Academic/Research
      • Biofuels
      • BioPharm Insurance
      • Biopharma
      • Biotech
      • Clinical Research
      • Contract Research
      • Cosmeceuticals
      • Diagnostics
      • Environmental
      • Featured
      • Genetics
      • Incubator/Accelerator
      • Legal
      • Manufacturing
      • Medical Devices
      • Pharmaceutical
      • Premium
      • Services
      • Supplements
      • Suppliers
      • Venture Capital
  • Service Providers
    • Services
      • Analytical Chemistry
      • Animal
      • Biochemistry
      • Bioprocess Contract
      • Biorepository
      • Cell Biology
      • Cell Culture
      • Chemistry
      • Clinical Research
      • Construction
      • Consulting
      • Contract Manufacturers
      • Contract Pharma
      • Contract Research
    • Suppliers
      • Biospecimens
      • Lab Equipment
      • Manufacturing
      • Meters
      • Microarrays
      • Microscopes
      • Miscellaneous
      • Molecular Biology
      • Packaging
      • Protein
      • Reagents
      • Research Tools
      • RNAi Technology
      • Safety & Hygiene
      • Sample Prep
      • Software Quality
      • Testing Systems
      • Vacuum Equipment
  • Channels
    • Regional Channels
      • Austin
      • College Station
      • Dallas / Fort Worth
      • El Paso
      • Galveston
      • Houston
      • Lubbock
      • San Antonio
    • Topic Channels
      • Alzheimer’s
      • Autism & Autism Spectrum Disorder: What You Need To Know
      • Autosomal Recessive Disease: What You Need To Know
      • Biofuels
      • Biomarkers: What You Need To Know
      • Biomaterials – Biospecimens
      • Brain Cancer: What You Need To Know
      • Cardiovascular
      • Chagas Disease: What You Need To Know
      • Cancer
      • Clostridium Difficile: What You Need To Know
      • Crohn’s Disease: What You Need To Know
      • Cystic Fibrosis: What You Need to Know
      • Dengue Fever: What You Need To Know
      • Depression
      • Ewing’s Sarcoma: What You Need To Know
      • Genetics
      • H7N9: What You Need To Know
      • Hepatitis B: What You Need To Know
      • Infectious Disease
      • Influenza: What You Need To Know
      • Leukemia: What You Need To Know
      • Liver Cancer: What You Need To Know
      • Lung Cancer: What You Need To Know
      • Medical Device
      • Myocardial Ischemia: What You Need To Know
      • Neglected Tropical Diseases: What You Need To Know
      • Neurology
      • Obesity: What You Need To Know
      • Peter Hotez: What You Need To Know
      • Prostate Cancer: What You Need To Know
      • Quantum Dots: What You Need To Know
      • Secondary Progressive MS: What You Need To Know
      • Spinal Muscular Atrophy: What You Need To Know
      • T-Cells: What You Need To Know
      • 3D Technology: What You Need To Know
      • Triple Negative Breast Cancer: What You Need To Know
      • West Nile Virus: What You Need To Know
  • About
  • Advertise
  • Follow
    • Facebook
    • Twitter
    • Google+
    • Linkedin
    • Pinterest
TAMU’s Robert Tribble Named Brookhaven Lab’s Deputy Director for Science and Technology
Home
News

TAMU’s Robert Tribble Named Brookhaven Lab’s Deputy Director for Science and Technology

February 20th, 2014 Mike Nace 0 comments

Dr. Robert TribbleA prominent researcher and professor from Texas A&M has been named Deputy Director for Science & Technology at the U.S. Department of Energy’s Brookhaven National Laboratory. Dr. Robert Tribble, a world renowned physicist who as a researcher and thought leader in nuclear science in the U.S. has contributed to its progress and advancements, is currently a Distinguished Professor of Physics & Astronomy at Texas A&M University and Director of the Cyclotron Institute and the Nuclear Solutions Institute there. Now, Tribble will  work closely with the Laboratory Director, Associate and Assistant Lab Directors, and the Science & Technology Steering Committee of the Brookhaven Science Associates (BSA) Board to help steer the research institution’s future goals and focuses.

Dr. Tribble’s work is a testament to the DoE’s decision to appoint him to Brookhaven lab: he is well-known for his groundbreaking research into fundamental symmetries, the Standard Model, nuclear structure and reactions, nuclear astrophysics and proton spin — a broad spectrum of focuses in the Physics field — and is also recognized as a critical contributor to the development of new tools and techniques that have advanced his field. In addition to his academic and research prowess, Dr. Tribble has also held leadership positions germance to his new appointment, such as his service as a member or chair of numerous long-range planning committees for the American Physical Society (APS) and the Nuclear Science Advisory Committee (NSAC), an advisory committee for the Department of Energy and National Science Foundation.

Laboratory Director Doon Gibbs commented that, “We’re very excited to have Bob Tribble join Brookhaven Lab in a key leadership role,” adding that, “His unique experience and insight into science in this country and around the world will be a great asset as we chart our plans for future research programs.”

Despite its seemingly unassuming name, Brookhaven Lab is a major research facility, employing about 3,000 scientists, engineers, technicians and support staff, and hosting 5,000 visiting scientists each year, with a substantial annual budget of around $700 million.

“The college would like to congratulate Dr. Tribble for being offered this distinguished position while still maintaining a strong connection with our Nuclear Science group here at Texas A&M University,” said Dr. H. Joseph Newton, dean of the Texas A&M College of Science. “If anyone deserves such a position, it is him, and we look forward to seeing the impact he is able to make on this national lab.”

 

 

 

“Brookhaven Lab is a fantastic resource for New York State, the region, and the nation,” Tribble said. “With two major accelerator facilities — the powerful new National Synchrotron Light Source II and the Relativistic Heavy Ion Collider (RHIC) — it carries on the tradition of investigating fundamentals of science that have been the hallmark of the Lab since its beginnings. I’m deeply honored to join the team that will move the Lab forward in taking on new challenges, from expanding RHIC to the electron-ion collider eRHIC, to synthesizing new nanomaterials for materials and biosciences, to improving energy efficiency and developing new sustainable energy sources for the nation.”

 

Tribble earned his B.S. with honors in physics from the University of Missouri, Columbia (1969) and his Ph.D. from Princeton University (1973). He joined the Texas A&M University faculty in 1975, served as Head of the Department of Physics from 1979-87, and has served as Director of the Cyclotron Institute since 2003. His numerous honors and awards include being named an Alfred P. Sloan Fellow (1976-80), a Fellow of the American Physical Society (1982), an honorary doctorate from Saint Petersburg State University, Russia (2009), and various awards recognizing his excellence in teaching and research.

 

Tribble has served as a member or chair of numerous committees for the APS and NSAC. He led the development of the most recent NSAC Long Range Plan for Nuclear Science, served on a recent Global Science Forum panel that evaluated the state of nuclear physics facilities around the world, was a member and is now chair of the International Union of Pure and Applied Physics Working Group 9, and was a member of the National Research Council decadal survey for nuclear physics, NP2010. Most recently, he chaired an NSAC subcommittee charged with making recommendations for achieving the vision of the Long Range Plan under constrained budget scenarios. In that capacity he played a key role in communicating the importance of the U.S. Nuclear Science program — including research that takes place at Brookhaven Lab’s Relativistic Heavy Ion Collider — and building support for an achievable path to maintain U.S. leadership in this field.

 

About Brookhaven National Laboratory: One of 10 national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE’s Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.

Share this article

Next article CytRx's Aldoxorubicin Initiates Phase 2 Study for the Treatment of HIV-derived Kaposi's Sarcoma
Previous article UTMB Professor Named to National Advisory Council

Mike Nace

Mike Nace is the Editor-in-Chief of BioNewsTexas. He regularly covers corporate and political news pertaining to the Texas biotech sector.

Popular Tags

20th annual Vulcan Materials Funshoot 340B 2014 World Stem Cell Summit austin BIG DATA bioaustin biorepositories biospecimens blog Cancer Therapy & Research Center Chemistry Chuck Reed College Station CPRIT CPRIT Foundation crowdfunding cystic fibrosis Dallas DFW drug discount enventure fort worth Funding Galveston GlaxoSmithKline Governor Rick Perry Greatbatch Greg Abbott Health Industry Council of North Texas houston How to Support People With MS Jennifer Stevens lab Medical Device Multiple Sclerosis Multiple Sclerosis Support Obama Obamacare Primary Progressive Multiple Sclerosis san antonio Sante Ventures SB 149 Signs Of MS Texas A&M thbi

Archives

  • Texas’ Only Source For Biotech & Life Sciences News
  • About
  • News
  • Terms of Use
  • Privacy Policy
  • Contact
  • Back to top
© BioNews Services
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more